From: MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system
PFS
HR
95Â % CI
P
Age
0.983
0.922–1.049
0.605
N-B, 2–3
1.146
0.464–2.830
0.768
MSKCC, 2–3
4.975
0.715–34.613
0.105
MYC (≥40) and BCL2 (≥60), dual positive
4.372
1.430–13.367
0.010